A comparison of novel developed centrifugal-flow and conventional pulsatile-flow extracorporeal left ventricular assist devices in patients with cardiogenic shock : Sub-analysis of NCVC-BTD_01 trial
Not Applicable
Recruiting
- Conditions
- Patients who were implanted with extracorporeal left ventricular assist device at the National Cerebral and Cardiovascular Center in Japan
- Registration Number
- JPRN-UMIN000040456
- Lead Sponsor
- ational Cerebral and Cardiovascular Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 85
Inclusion Criteria
Not provided
Exclusion Criteria
Subjects without informed consent
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method We assess the death and major cardiac events 60 days after ELVAD implantation.
- Secondary Outcome Measures
Name Time Method We also assess the changes in organ dysfunction including liver and renal function and cardiac function early phase after E-LVAD implantation.